Allon Therapeutics NPCUF Stock
Allon Therapeutics Price Chart
Allon Therapeutics NPCUF Financial and Trading Overview
| Allon Therapeutics stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.001 USD |
| Volume | 3K USD |
| Avg. Volume | 23 USD |
| Market Cap | 14.11K USD |
| Beta (5Y Monthly) | 3731.169 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NPCUF Valuation Measures
| Enterprise Value | -390858 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.045 |
Trading Information
Allon Therapeutics Stock Price History
| Beta (5Y Monthly) | 3731.169 |
| 52-Week Change | -90.00000000000000000000000000000000% |
| S&P500 52-Week Change | 29.00% |
| 52 Week High | 0.001 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000406 USD |
| 200-Day Moving Average | 0.00046 USD |
NPCUF Share Statistics
| Avg. Volume (3 month) | 23 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 141.1M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2012 |
| Most Recent Quarter (mrq) | March 31, 2013 |
| Next Fiscal Year End | December 31, 2013 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -154.84% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -8727119 USD |
| Net Income Avi to Common (ttm) | -13208904 USD |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 589.48K USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 184.52K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.312 |
| Book Value Per Share (mrq) | -0.00948766 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7652251 USD |
| Levered Free Cash Flow (ttm) | -4524245 USD |
Profile of Allon Therapeutics
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1168 Hamilton Street |
| ZIP | V6B 2S2 |
| Phone | 604-736-0634 |
| Website | https://www.allontherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004. Allon Therapeutics Inc. was incorporated in 1994 and is headquartered in Vancouver, Canada.
Q&A For Allon Therapeutics Stock
What is a current NPCUF stock price?
Allon Therapeutics NPCUF stock price today per share is 0.0001 USD.
How to purchase Allon Therapeutics stock?
You can buy NPCUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Allon Therapeutics?
The stock symbol or ticker of Allon Therapeutics is NPCUF.
Which industry does the Allon Therapeutics company belong to?
The Allon Therapeutics industry is Biotechnology.
How many shares does Allon Therapeutics have in circulation?
The max supply of Allon Therapeutics shares is 141.1M.
What is Allon Therapeutics Price to Earnings Ratio (PE Ratio)?
Allon Therapeutics PE Ratio is 0.00000000 now.
What was Allon Therapeutics earnings per share over the trailing 12 months (TTM)?
Allon Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Allon Therapeutics company belong to?
The Allon Therapeutics sector is Healthcare.